NCT02031471 TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment Status COMPLETED Phase PHASE3
NCT02029599 The Efficacy and Safety of Fang yi Qing Feng Shi Granules in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT02028624 Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis Status COMPLETED Phase NA
NCT02027298 Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study Status WITHDRAWN Phase PHASE2
NCT02026245 A Comparison of Two Electronic Gloves in the Measurement of Joint Movement in Patients With Rheumatoid Arthritis Status COMPLETED Phase NA
NCT02019602 A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta Status COMPLETED Phase PHASE1
NCT02015520 Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT02012764 The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ? Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02011334 A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs. Status COMPLETED Phase PHASE3
NCT02010216 A Study of RoActemra/Actemra (Tocilizumab) in Adult Patients With Rheumatoid Arthritis (SVOBODA Programme) Status COMPLETED Phase PHASE4
NCT02008266 Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02006706 A Study of MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy Status COMPLETED Phase PHASE3
NCT02005757 Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED) Status UNKNOWN Phase PHASE2
NCT02001987 A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy Status COMPLETED Phase PHASE3
NCT01999192 Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01995201 A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01990157 Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1/PHASE2